Biocon Pharma recalls 40mg Atorvastatin Calcium Tablets due to failed dissolution specifications. This may affect medication effectiveness. Contact for details.
“Biocon Pharma Atorvastatin 40mg Tablets Recall: Failed Dissolution Specifications.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32180-biocon-pharma-atorvastatin-40mg-tablets-recall-failed-dissolution-specifications. Based on FDA recall #D-0306-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0306-2025%22&limit=1).
The FDA announced on March 17, 2025, that Biocon Pharma Inc. is recalling Atorvastatin Calcium Tablets USP 40 mg due to failed dissolution specifications. The Class II recall affects 2,184 bottles distributed nationwide.
The tablets have failed dissolution specifications, resulting in lower than required dissolution levels. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show Biocon Pharma Inc. has one other recall on record since January 31, 2023, involving Posaconazole Tablets due to high impurities risk. Other recent recalls of similar products include AvKARE Rosuvastatin Tablets 10mg Recall (December 31, 2025), Teva Metoprolol Succinate Tablets Recall (January 29, 2026), and Mylan Acamprosate Tablets Recall (July 24, 2026).
How to tell if you have this one
Check for the 1000-count bottle labeled 'Atorvastatin Calcium Tablets USP 40 mg, Rx Only'. The NDC code is 70377-079-13 and it was manufactured in India with lot number AVC24035.
Brand
Biocon Pharma
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Medication Details
Look for the NDC code 70377-079-13 on the bottle label to confirm if it's recalled.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “U.S.A. nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 23 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0306-2025 (March 17, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0306-2025 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.